Laurion Capital Management LP Anebulo Pharmaceuticals, Inc. Transaction History

Laurion Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.15 $592,874 - $1.57 Million	-219,583 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.0 - $7.7 $32,502 - $41,710	-5,417 Reduced 2.41%	219,583 $1.48 Million
Q2 2021 Aug 13, 2021	BUY	$6.58 - $8.95 $1.48 Million - $2.01 Million	225,000 New	225,000 $1.55 Million

7.34M

Ticker ANEB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,633,200
Market Cap $40.2M
Description
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.